Evidence map›Paper›PMID 23821341›Full record

ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2013

Induction of experimental autoimmune encephalomyelitis with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant in three non-human primate species.

Krista G Haanstra, S Anwar Jagessar, Anne-Laure Bauchet, Mireille Doussau, Claire-Maëlle Fovet, Nicole Heijmans, Sam O Hofman, Jennifer van Lubeek-Veth, Jeffrey J Bajramovic, Yolanda S Kap and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Poster Presentations.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Article
  11. Review
  12. Article
  13. PART 2: Mouse models for multiple sclerosis research.Neurourology and urodynamics · 2021
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 3 countries.

Krista G HaanstraDepartment of Immunobiology, Biomedical Primate Research Centre, P.O. Box 3306, 2280 GH, Rijswijk, The Netherlands.
S Anwar Jagessar
Anne-Laure Bauchet
Mireille Doussau
Claire-Maëlle Fovet
Nicole Heijmans
Sam O Hofman
Jennifer van Lubeek-Veth
Jeffrey J Bajramovic
Yolanda S Kap
Jon D Laman
Hélène Touin
Laurent Watroba
Jan Bauer
François Lachapelle
Che Serguera
Bert A 't Hart
Biomedical Primate Research Centre · NLCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRInserm · FRErasmus MC · NLCEA Paris-Saclay - Etablissement de Fontenay-aux-roses · FRMedical University of Vienna · ATUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The experimental autoimmune encephalitis (EAE) model is used for preclinical research into the pathogenesis of multiple sclerosis (MS), mostly in inbred, specific pathogen free (SPF)-raised laboratory mice. However, the naive state of the laboratory mouse immune system is considered a major hurdle in the translation of principles from the EAE model to the MS patient. Non-human primates (NHP) have an immune system harboring T- and B-cell memory against environmental antigens, similar as in humans. We sought to further refine existing NHP EAE models, which may help to bridge the gab between mouse EAE models and MS. We report here on new EAE models in three NHP species: rhesus monkeys (Macaca mulatta), cynomolgus monkeys (Macaca fascicularis) and common marmosets (Callithrix jacchus). EAE was induced with recombinant human myelin oligodendrocyte glycoprotein extracellular domain (1-125) (rhMOG) formulated in incomplete Freund's adjuvant (IFA). IFA lacks the bacterial antigens that are present in complete Freund's adjuvant (CFA), which are notorious for the induction of discomforting side effects. Clinically evident EAE could be induced in two out of five rhesus monkeys, six out of six cynomolgus monkeys and six out of six common marmosets. In each of these species, the presence of an early, high anti-rhMOG IgM response is correlated with EAE with an earlier onset and more severe disease course. Animals without an early high IgM response either did not develop disease (rhesus monkeys) or developed only mild signs of neurological deficit (marmoset and cynomolgus monkeys).

Indexed as

Adjuvants, ImmunologicAnimalsBrainCallithrixEncephalomyelitis, Autoimmune, ExperimentalFreund's AdjuvantHumansImmunoglobulin MImmunohistochemistryMacaca fascicularisMacaca mulattaMyelin-Oligodendrocyte GlycoproteinRecombinant ProteinsSpinal CordAdjuvants, ImmunologicFreund's AdjuvantImmunoglobulin MMOG protein, humanMyelin-Oligodendrocyte GlycoproteinRecombinant Proteins

Identifiers

PMID23821341
PMCPMC3889224
OpenAlexW2165148901

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.